Three independent lot files
GLP-3 (R), MOTS-C, and AOD9604 each ship with separate paperwork.
Sale
WEIGHT MANAGEMENT BUNDLE
$288.98
Purity (HPLC)≥99%
Storage2–8 °C
- Third-party testedIndependent lab verified
- Batch-specific COAsAvailable for each compound in the bundle
- Tracked shippingDispatched with tracking
- Secure checkoutEncrypted payment
Questions before ordering? Our team can confirm documentation, stock and shipping.
- Research Use Only
- Third-Party Tested
- COA Access Available
- Laboratory Use Only
Key Specifications
Specifications for each compound are listed individually below.
| Compound | GLP-3 (R) | MOTS-C | AOD9604 |
|---|---|---|---|
| Quantity | 5mg | 10mg | 10mg |
| Product format | Research-grade triple-receptor agonist peptide | Research-grade mitochondrial-derived peptide | Research-grade hGH fragment (176-191) |
| Intended use | Laboratory research only | Laboratory research only | Laboratory research only |
| Documentation | COA available through our COA library | COA available through our COA library | COA available through our COA library |
| Related category | Metabolic Peptide Research | Mitochondrial & Metabolic Peptide Research | Metabolic Peptide Research |
Research Use Only
This bundle is sold exclusively to laboratories and qualified researchers, and none of the three compounds carry approval for human or animal administration, diagnosis, or treatment.
Review the compliance section and each compound's storage guidance before submitting an order.
What is the Weight Management Research Bundle?
AOD9604 is a modified 16-amino-acid fragment of the human growth hormone C-terminus, isolated by Monash University researchers who found that the region spanning residues 176-191 carries GH's fat-mobilizing activity without the growth-promoting or IGF-1-elevating effects tied to the rest of the molecule. It doesn't engage the classical GH receptor at all; instead, research links its lipolytic activity to beta-3 adrenergic receptor upregulation on adipocytes, which raises intracellular cAMP and activates hormone-sensitive lipase to break down stored triglycerides.
That mechanism sits apart from both other compounds in this bundle. GLP-3 (R) works upstream of the adipocyte entirely, engaging GLP-1, GIP, and glucagon receptors to influence appetite signaling and hepatic glucose output. MOTS-C works from inside the cell, a mitochondrially encoded peptide that activates AMPK once energy status shifts, connecting cellular fuel sensing to broader metabolic adaptation. None of the three compounds compete for the same receptor or cellular compartment, which is what lets a lab study appetite regulation, mitochondrial signaling, and direct lipolysis as independent variables within one weight-management research model.
Product Details
Three compounds, three separate points of intervention in fat metabolism research.
- GLP-3 (R)Triple receptor agonist studied across GLP-1R, GIPR, and GCGR for appetite and glucose regulation.
- MOTS-CMitochondrially encoded peptide studied for AMPK activation and cellular energy sensing.
- AOD9604hGH fragment (176-191) studied for beta-3 adrenergic receptor-mediated lipolysis, independent of classical GH receptor engagement.
Purity Verification and COA Access
Each of the three vials in this bundle ships with its own lot-specific record, letting a researcher confirm the exact batch received rather than relying on a single certificate covering the full set.
Why Cellugenix for Weight Management Research Bundle?
This bundle is documented to the same standard applied across the full Cellugenix catalog.
Outside lab confirmation
Identity and purity for every batch are verified by a third party.
Restricted to research buyers
None of the three compounds are marketed beyond laboratory use.
Single tracked shipment
All three vials travel together under one tracking number.
Individually cushioned vials
Each item is packed separately within the shipment.
Storage and Handling
A receptor agonist, a mitochondrial peptide, and a GH fragment each carry distinct stability requirements, so review the guidance for every compound individually.
- Compound-specific conditionsGLP-3 (R), MOTS-C, and AOD9604 each have their own temperature and reconstitution notes.
- File records by vialMatch each COA to its corresponding compound for easy reference.
- Check before prepOpen the individual handling page for any compound before reconstituting it.
Related Research Category
This bundle spans two categories across the Cellugenix catalog.
Quality and Documentation
Reference pages for testing standards and ordering policy.
Frequently Asked Questions
What's in the Weight Management Research Bundle, and how much of each?
GLP-3 (R) at 5mg, MOTS-C at 10mg, and AOD9604 at 10mg, each shipped as its own documented vial.
AOD9604 comes from growth hormones. Does it carry the same effects as full-length GH?
No. Research indicates AOD9604 reproduces GH's lipolytic activity through beta-3 adrenergic receptor upregulation while bypassing the classical GH receptor, meaning it doesn't raise IGF-1 or trigger the insulin-antagonistic effects associated with full-length GH.
Do GLP-3 (R) and AOD9604 act on the same fat-loss mechanism?
No. GLP-3 (R) works through gut hormone receptors to influence appetite and glucose handling, while AOD9604 acts directly on adipocytes to promote lipolysis, a separate mechanism entirely.
Is a COA supplied individually for each of the three compounds?
Yes, GLP-3 (R), MOTS-C, and AOD9604 each have their own batch record accessible through the COA library.
Can all three peptides be stored the same way?
No, each has a distinct stability profile, so check the individual handling page for GLP-3 (R), MOTS-C, and AOD9604 separately.
Need Product Support?
Do you have questions about order quantities, delivery timing, or anything else before you check out? Reach out and we'll help you get it sorted.
